Hematopoietic Stem Cell (HSC) Mobilization Therapeutics – Pipeline Analysis 2018

Mobilization is the recruitment of hematopoietic stem cells (HSC) into peripheral blood from the bone marrow following chemotherapy treatment. There are several advantages for reinfusion of autologous mobilized peripheral blood stem cells over bone marrow HSC.

Download the sample report @ https://www.pharmaproff.com/request-sample/1134

Some of the major advantages include enhanced immune reconstitution, shorter duration of granulocytopenia, shorter hospital stays, reduced morbidity and mortality and saving of financial resources. Several factors, such as type and dose of cytokines, age, mobilizing chemotherapy regimen, interval from last chemotherapy cycle and type of previous chemotherapy cycles or radiation, affects HSC mobilization.

Get the detailed analysis @ https://www.pharmaproff.com/report/hsc-mobilization-therapeutics-pipeline-analysis

BioLineRx Ltd. is developing BL-8040, a short peptide which acts as a CXCR4 antagonist, for the treatment of HSC mobilization. Celldex Therapeutics Inc., and Aviara Pharmaceuticals Inc. are some other key players having pipeline drugs for HSC mobilization.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1134

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com

Web: https://www.pharmaproff.com

Connect with us on: LinkedIn | Twitter | Facebook